A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis

Open Access

Peer-reviewed

Research Article

Himanshu Naik,

Affiliation Pharmacometrics, Takeda Global Research and Development, Inc., Deerfield, Illinois, United States of America
⨯
Max C. Tsai,

Affiliation Pharmacometrics, Takeda Global Research and Development, Inc., Deerfield, Illinois, United States of America
⨯
Jill Fiedler-Kelly,

Affiliation Pharmacometric Services, Cognigen Corporation, Buffalo, New York, United States of America
⨯
Ping Qiu,

Affiliation Clinical Science, Takeda Global Research and Development, Inc., Deerfield, Illinois, United States of America
⨯
Majid Vakilynejad

* E-mail: majid.vakilynejad@takeda.com

Affiliation Pharmacometrics, Takeda Global Research and Development, Inc., Deerfield, Illinois, United States of America
⨯

Reader Comments (0)

Hemoglobin
Is the Subject Area "Hemoglobin" applicable to this article?

Thanks for your feedback.
Medical dialysis
Is the Subject Area "Medical dialysis" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Red blood cells
Is the Subject Area "Red blood cells" applicable to this article?

Thanks for your feedback.
Chronic kidney disease
Is the Subject Area "Chronic kidney disease" applicable to this article?

Thanks for your feedback.
Erythropoietin
Is the Subject Area "Erythropoietin" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.
Precursor cells
Is the Subject Area "Precursor cells" applicable to this article?

Thanks for your feedback.